1. Home
  2. CCEL vs DTST Comparison

CCEL vs DTST Comparison

Compare CCEL & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • DTST
  • Stock Information
  • Founded
  • CCEL 1989
  • DTST 2001
  • Country
  • CCEL United States
  • DTST United States
  • Employees
  • CCEL N/A
  • DTST N/A
  • Industry
  • CCEL Managed Health Care
  • DTST EDP Services
  • Sector
  • CCEL Health Care
  • DTST Technology
  • Exchange
  • CCEL Nasdaq
  • DTST Nasdaq
  • Market Cap
  • CCEL 36.7M
  • DTST 32.6M
  • IPO Year
  • CCEL 1997
  • DTST N/A
  • Fundamental
  • Price
  • CCEL $4.72
  • DTST $4.54
  • Analyst Decision
  • CCEL Strong Buy
  • DTST
  • Analyst Count
  • CCEL 1
  • DTST 0
  • Target Price
  • CCEL $8.50
  • DTST N/A
  • AVG Volume (30 Days)
  • CCEL 17.6K
  • DTST 88.4K
  • Earning Date
  • CCEL 10-14-2025
  • DTST 08-14-2025
  • Dividend Yield
  • CCEL 12.77%
  • DTST N/A
  • EPS Growth
  • CCEL N/A
  • DTST N/A
  • EPS
  • CCEL N/A
  • DTST N/A
  • Revenue
  • CCEL $31,988,783.00
  • DTST $25,455,742.00
  • Revenue This Year
  • CCEL $1.75
  • DTST $12.57
  • Revenue Next Year
  • CCEL N/A
  • DTST $9.29
  • P/E Ratio
  • CCEL N/A
  • DTST N/A
  • Revenue Growth
  • CCEL 1.10
  • DTST 0.53
  • 52 Week Low
  • CCEL $4.09
  • DTST $2.93
  • 52 Week High
  • CCEL $9.43
  • DTST $5.44
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 51.06
  • DTST 52.40
  • Support Level
  • CCEL $4.21
  • DTST $4.55
  • Resistance Level
  • CCEL $4.82
  • DTST $4.65
  • Average True Range (ATR)
  • CCEL 0.26
  • DTST 0.16
  • MACD
  • CCEL 0.03
  • DTST -0.03
  • Stochastic Oscillator
  • CCEL 84.00
  • DTST 54.76

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: